Inflammatory mediator bradykinin increases population of sensory neurons expressing functional T-type Ca(2+) channels
- Biochem Biophys Res Commun. 2016 Apr 29;473(2):396-402. doi: 10.1016/j.bbrc.2016.02.118.
- 1. Department of Pharmacology, Hebei Medical University, Shijiazhuang, PR China.
- 2. Department of Pharmacology, Hebei Medical University, Shijiazhuang, PR China; School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK. Electronic address: [email protected].
- 3. Department of Pharmacology, Hebei Medical University, Shijiazhuang, PR China. Electronic address: [email protected].
T-type CA(2+) channels are important regulators of peripheral sensory neuron excitability. Accordingly, T-type CA(2+) currents are often increased in various pathological pain conditions, such as inflammation or nerve injury. Here we investigated effects of inflammation on functional expression of T-type CA(2+) channels in small-diameter cultured dorsal root ganglion (DRG) neurons. We found that overnight treatment of DRG cultures with a cocktail of inflammatory mediators bradykinin (BK), adenosine triphosphate (ATP), norepinephrine (NE) and prostaglandin E2 (PGE2) strongly increased the population size of the small-diameter neurons displaying low-voltage activated (LVA, T-type) CA(2+) currents while having no effect on the peak LVA current amplitude. When applied individually, BK and ATP also increased the population size of LVA-positive neurons while NE and PGE2 had no effect. The PLC inhibitor U-73122 and B2 receptor antagonist, Hoe-140, both abolished the increase of the population of LVA-positive DRG neurons. Inflammatory treatment did not affect CaV3.2 mRNA or protein levels in DRG cultures. Furthermore, an ubiquitination inhibitor, MG132, did not increase the population of LVA-positive neurons. Our data suggest that inflammatory mediators BK and ATP increase the abundance of LVA-positive DRG neurons in total neuronal population by stimulating the recruitment of a 'reserve pool' of CaV3.2 channels, particularly in neurons that do not display measurable LVA currents under control conditions.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer
-
target: Bradykinin ReceptorResearch Areas: Endocrinology
-
target: P2X Receptor
-
Research Areas: Cardiovascular Disease